Published in Biochemistry on May 29, 2001
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A (2003) 3.77
Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci U S A (2002) 1.61
The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40
Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov (2010) 1.38
Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity. Biosci Rep (2006) 1.26
Elucidating glycosaminoglycan-protein-protein interactions using carbohydrate microarray and computational approaches. Proc Natl Acad Sci U S A (2011) 1.00
CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS One (2012) 1.00
Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine (2008) 0.99
Tunable heparan sulfate mimetics for modulating chemokine activity. J Am Chem Soc (2013) 0.94
The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology (2015) 0.91
Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines. Glycoconj J (2012) 0.89
In vitro and in vivo affinity microdialysis sampling of cytokines using heparin-immobilized microspheres. Anal Bioanal Chem (2010) 0.86
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES. Proteins (2010) 0.86
Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83
Heparin-immobilized microspheres for the capture of cytokines. Anal Bioanal Chem (2010) 0.83
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans. Front Immunol (2013) 0.82
A small molecule glycosaminoglycan mimetic blocks Plasmodium invasion of the mosquito midgut. PLoS Pathog (2013) 0.82
Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer. Biochemistry (2016) 0.80
The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH. J Biol Chem (2015) 0.80
Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans. Neoplasia (2012) 0.79
Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells. Sci Rep (2015) 0.79
Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5. Sci Rep (2014) 0.79
Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi. PLoS One (2010) 0.79
Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26. Front Immunol (2016) 0.79
Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands. Structure (2015) 0.78
Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs. Neoplasia (2014) 0.77
RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway. Biol Open (2014) 0.77
Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention. Mol Pharm (2013) 0.76
Identification, sequence characterization, and analysis of expression profiles of three novel CC chemokines from domestic duck (Anas platyrhynchos). Immunogenetics (2005) 0.75
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell (1996) 14.64
Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science (1989) 6.67
Cloning of genomic DNA for human atrial natriuretic factor. Biochem Biophys Res Commun (1984) 6.53
The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem (2001) 4.77
Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry (1996) 4.35
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett (1994) 3.78
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med (1997) 3.48
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell (1996) 3.44
Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem (1999) 3.35
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol (1997) 2.51
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J (1991) 2.23
Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem (1997) 2.12
Identification of a novel human ADP receptor coupled to G(i). J Biol Chem (2001) 2.05
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun (1990) 1.94
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol (1998) 1.88
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med (1998) 1.81
Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry (1986) 1.80
CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood (1999) 1.75
[Lyell syndrome following administration of erythromycin-sulfafurazole and morniflumate]. Arch Pediatr (1995) 1.74
Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J Virol (1999) 1.72
Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun (1996) 1.71
Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem (1995) 1.68
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem (1997) 1.62
The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J (1991) 1.57
Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57
On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures. J Biol Chem (1997) 1.57
The dust halo of Saturn's largest icy moon, Rhea. Science (2008) 1.52
Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J Leukoc Biol (1999) 1.50
Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity. Eur J Gastroenterol Hepatol (2001) 1.46
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol (2000) 1.42
The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J Biol Chem (1998) 1.42
Rheumatic heart disease and Sneddon's syndrome. Stroke (1994) 1.40
[Smoking and pregnancy: survey among women enrolled in an independent worker insurance program]. J Gynecol Obstet Biol Reprod (Paris) (2004) 1.39
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood (2001) 1.39
The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation. J Biol Chem (2001) 1.37
Impaired motor coordination and Purkinje cell excitability in mice lacking calretinin. Proc Natl Acad Sci U S A (1999) 1.37
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem (1999) 1.36
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity. J Biol Chem (1999) 1.34
CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry (2000) 1.33
Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett (1998) 1.33
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology (2002) 1.29
Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. Genomics (1997) 1.27
Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun (1990) 1.27
N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem (2001) 1.26
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci (2000) 1.25
Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J Biol Chem (2001) 1.24
Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia (1989) 1.23
Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry (2001) 1.21
Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol (1999) 1.19
Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem Biophys Res Commun (1992) 1.17
RNF4 is required for DNA double-strand break repair in vivo. Cell Death Differ (2012) 1.16
Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood (2000) 1.16
Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J (1995) 1.14
Cloning and tissue distribution of the human P2Y1 receptor. Biochem Biophys Res Commun (1996) 1.14
Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res (1990) 1.14
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology (Berl) (2000) 1.13
The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics (1996) 1.11
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem (2001) 1.11
The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem (2000) 1.09
Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics (1991) 1.09
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med (2000) 1.08
Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry (1994) 1.05
Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci U S A (1996) 1.03
Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology (1991) 1.02
Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol (2001) 1.01
Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J (1992) 1.00
Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acids Res (1990) 1.00
Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc Natl Acad Sci U S A (1997) 0.99
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity. Eur J Biochem (1997) 0.99
Expression of P2Y receptors in cell lines derived from the human lung. Br J Pharmacol (1999) 0.98
Olfactory receptors are displayed on dog mature sperm cells. J Cell Biol (1993) 0.98
Cloning and chromosomal mapping of the mouse and human genes encoding the orphan glucocorticoid-induced receptor (GPR83). Cytogenet Cell Genet (2000) 0.97
Sterilization reversal: fertility results. Hum Reprod (1995) 0.97
Spinal curvatures and quality of life in women with vertebral fractures secondary to osteoporosis. Spine (Phila Pa 1976) (1999) 0.97
Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages. AIDS (1998) 0.97
Solid-phase synthesis of peptides containing the spin-labeled 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC). J Pept Res (2001) 0.96
Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice. Proc Natl Acad Sci U S A (1990) 0.95
Selective cleavage of the single tryptophanyl peptide bond in horse heart cytochrome c. FEBS Lett (1973) 0.94
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience (2000) 0.94
Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology (2003) 0.93
Molecular cloning and chromosomal mapping of olfactory receptor genes expressed in the male germ line: evidence for their wide distribution in the human genome. Biochem Biophys Res Commun (1997) 0.93
Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor. Eur J Immunol (1996) 0.93